Fact CheckerSign in

Obesity: open trials in South Korea

36 open trials have a site in South Korea. Registry data; only the trial team decides who can take part.

  • NCT07595549

    A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

    Trial Treatment · Phase 3 · Pfizer

    Hallym University Sacred Heart Hospital, Anyang-si · Konyang University Hospital, Daejeon · Gachon University Gil Medical Center, Incheon · Kangbuk Samsung Hospital, Seoul · Pusan National University Yangsan Hospital, Yangsan

    Registry updated 2026-11-05

  • NCT07794579

    A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

    Trial Treatment · Phase 3 · Eli Lilly and Company

    Korea University Ansan Hospital, Ansan-si · Hallym University Sacred Heart Hospital, Anyang-si · Pusan National University Yangsan Hospital, Busan · Hanyang University Guri Hospital, Guri-si · Chosun University Hospital, Gwangju · Kyungpook National University Hospital, Junggu · Konyang University Hospital, Seogu · Seoul National University Bundang Hospital, Seongnam · CHA Bundang Medical Center, CHA University, Seongnam-si · Seoul National University Hospital, Seoul · Hanyang University Seoul Hospital, Seoul · Korea University Anam Hospital, Seoul

    Registry updated 2026-11-05

  • NCT06672549

    A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

    Trial Treatment · Phase 3 · Eli Lilly and Company

    Seoul National University Bundang Hospital, Seongnam-si · Korea University Guro Hospital, Seoul · Hanyang University Seoul Hospital, Seoul · Asan Medical Center, Seoul

    Registry updated 2026-11-04

  • NCT07202884

    A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight

    Trial Treatment · Phase 3 · Eli Lilly and Company

    Hallym University Sacred Heart Hospital, Anyang-si · The Catholic University of Korea, Bucheon St. Mary's Hospital, Bucheon-si · Pusan National University Hospital, Busan · Chonnam National University Hospital, Gwangju · Kyungpook National University Hospital, Junggu · Severance Hospital, Yonsei University Health System, Seoul · Samsung Medical Center, Seoul

    Registry updated 2026-11-04

  • NCT07282600

    A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

    Trial Treatment · Phase 3 · Eli Lilly and Company

    Korea University Ansan Hospital, Ansan-si · Hanyang University Guri Hospital, Guri-si · Chosun University Hospital, Gwangju · Seoul National University Bundang Hospital, Seongnam · Severance Hospital, Yonsei University Health System, Seoul

    Registry updated 2026-11-04

  • NCT07353931

    Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

    Trial Treatment · Phase 3 · Eli Lilly and Company

    Keimyung University Dongsan Hospital, Daegu · Boramae Medical Center, Dongjak-gu · Severance Hospital, Yonsei University Health System, Seoul · Asan Medical Center, Seoul · Seoul National University Hospital, Seoul · The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul · Hallym University Kangnam Sacred Heart Hospital, Seoul · The Catholic University of Korea Uijeongbu St. Mary's Hospital, Uijeongbu-si

    Registry updated 2026-11-04

  • NCT07369011

    A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

    Trial Treatment · Phase 3 · Eli Lilly and Company

    Korea University Ansan Hospital, Ansan-si · Korea University Guro Hospital, Seoul · Asan Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul

    Registry updated 2026-11-04

  • NCT07817875

    Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)

    Trial Treatment · Phase 3 · Eli Lilly and Company

    Seoul National University Bundang Hospital, Seongnam-si · Korea University Guro Hospital, Seoul · Asan Medical Center, Seoul

    Registry updated 2026-11-04

  • NCT07881458

    A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

    Trial Treatment · Phase 3 · Eli Lilly and Company

    Korea University Ansan Hospital, Ansan-si · Chosun University Hospital, Gwangju · Seoul National University Bundang Hospital, Seongnam · Nowon Eulji Medical Center, Eulji University, Seoul · Severance Hospital, Yonsei University Health System, Seoul

    Registry updated 2026-11-04

  • NCT07881432

    A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes

    Trial Treatment · Phase 3 · Eli Lilly and Company

    Korea University Ansan Hospital, Ansan-si · Pusan National University Yangsan Hospital, Busan · Hanyang University Guri Hospital, Guri-si · Chosun University Hospital, Gwangju · Yeungnam Univeristy Medical Center, Gyeongsan-si · Kyungpook National University Hospital, Junggu · Gachon University Gil Medical Center, Namdong-gu · Konyang University Hospital, Seogu · Seoul National University Bundang Hospital, Seongnam · CHA Bundang Medical Center, CHA University, Seongnam-si · Nowon Eulji Medical Center, Eulji University, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Seoul National University Hospital, Seoul

    Registry updated 2026-11-03

  • NCT07900633

    A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk

    Trial Treatment · Phase 3 · Eli Lilly and Company

    The Catholic University of Korea, Bucheon St. Mary's Hospital, Bucheon-si · Kosin University Gospel Hospital, Busan · Hanyang University Guri Hospital, Guri-si · Chosun University Hospital, Gwangju · Yeungnam Univeristy Medical Center, Gyeongsan-si · Inha University Hospital, Incheon · Konyang University Hospital, Seogu · Seoul National University Bundang Hospital, Seongnam · Korea University Anam Hospital, Seoul · The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul · Asan Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Nowon Eulji Medical Center, Eulji University, Seoul · Ulsan University Hospital, Ulsan · Yonsei University Wonju Severance Christian Hospital, Wŏnju

    Registry updated 2026-11-03

  • NCT07784725

    Registry updated 2026-10-30

  • NCT07037459

    Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

    Trial Treatment · Phase 3 · Amgen

    Chungnam National University Hospital, Daejeon · Chonnam National University Hospital, Gwangju · Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do · Seoul National University Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Yonsei University Wonju Severance Christian Hospital, Wonju-si, Gangwon-do

    Registry updated 2026-10-29

  • NCT07784270

    A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

    Trial Treatment · Phase 3 · AstraZeneca

    Busan · Daegu · Daejeon · Incheon · Seoul · Suwon

    Registry updated 2026-10-28

  • NCT07351045

    A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

    Trial Treatment · Phase 3 · Hoffmann-La Roche

    Kyungpook National University Hospital, Daegu · Konyang University Hospital, Daejeon · Chosun University Hospital, Gwangju · Hanyang University Guri Hospital, Gyeonggi-do · Bucheon St Mary's hospital, Gyeonggi-do · Gachon University Gil Medical Center, Incheon · Seoul National University Bundang Hospital, Seongnam-si · Asan Medical Center, Seoul · Kangbuk Samsung Hospital, Seoul · Seoul National University Hospital, Seoul

    Registry updated 2026-10-13

  • NCT07351058

    A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

    Trial Treatment · Phase 3 · Hoffmann-La Roche

    Eulji University Hospital, Daejeon · Yonsei University Wonju Severance christian hospital, Gangwon-do · Chosun University Hospital, Gwangju · Uijeongbu St. Mary's Hospital, Gyeonggi-do · Seoul National University Bundang Hospital, Seongnam-si · Gangdong Kyung Hee University Hospital, Seoul · Hallym University Kangnam Sacred Heart Hospital, Seoul · Kangbuk Samsung Hospital, Seoul · Eulji general hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul

    Registry updated 2026-10-13

  • NCT07667803

    A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

    Trial Treatment · Phase 3 · AstraZeneca

    Busan · Daegu · Goyang-si · Gyeonggi-do · Incheon · Jongno-gu · Seoul · Suwon

    Registry updated 2026-10-13

  • NCT07861100

    A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity

    Trial Treatment · Phase 3 · Novo Nordisk A/S

    The Catholic University of Korea, Bucheon St. Mary's Hospital, Bucheon-si · Dong-A University Hospital, Busan · Pusan National University Hospital, Busan · Keimyung University Dongsan Hospital, Daegu · Kyungpook National University Hospital_Cardiology, Daegu · Yeungnam Univ. Medical Center, Daegu · Daegu Catholic Univ. Medical Center, Daegu · Chungnam National University Hospital, Daejeon · Wonju Severance Christian Hospital, Gangwon-do · Chonnam National University Hospital, Gwangju · Chung-Ang University Gwangmyeong Hospital, Gyeonggi-do · Inha University Hospital, Incheon · Seoul National University Bundang Hospital, Seongnam-si · Kyung Hee University Hospital at Gangdong, Seoul · Ewha Womans University Seoul Hospital, Seoul · Korea University Anam Hospital, Seoul · Chung ang University Hospital, Seoul · Ajou University Hospital, Suwon · The Catholic University of Korea Uijeongbu St. Mary's Hospital, Uijeongbu-si · Ulsan University Hospital, Ulsan · Pusan National University Yangsan Hospital, Yangsan · Yongin Severance Hospital, Yŏngin

    Registry updated 2026-10-06

  • NCT07280221

    WEgovy Real World Assessment of Weight Loss in Korea

    Research · Novo Nordisk A/S

    Inje University Haeundae Paik Hospital, Busan · Dong-A University Hospital, Busan · Keimyung University Dongsan Hospital, Daegu · Daejeon Endo Internal Medicine Clinic, Daejeon · Konyang University Hospital, Daejeon · National Health Insurance Corporation Ilsan Hospital, Goyang-si · Chung-Ang University Gwangmyeong Hospital, Gwangmyeong-si, Gyeonggi-do · Seoul National University Bundang Hospital, Seongnam-si · Seoul Happiness Clinic of internal medicine, Seongnam-si, Gyeonggi-do · CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do · Ewha Womans University Seoul Hospital, Seoul · Chung ang University Hospital, Seoul · Korea University Guro Hospital, Seoul · Ajou University Hospital, Suwon · The Catholic University of Korea Uijeongbu St. Mary's Hospital, Uijeongbu-si · Uijeongbu Eulji university Hospital, Uijeongbu-si, Gyeonggi-do · Pusan National University Yangsan Hospital, Yangsan · Yongin Severance Hospital, Yongin-si

    Registry updated 2026-09-30

  • NCT07533175

    AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

    Trial Treatment · Phase 3 · Novo Nordisk A/S

    Chonnam National University Hospital_Endocrinology, Gwangju · Seoul National University Hospital_Endocrinology, Seoul · Asan Medical Center_Endocrinology, Seoul · The Catholic University of Korea, Yeouido ST. Mary's Hospital_Endocrinology, Seoul · Kyunghee University Medical Center_Endocrinology, Seoul · Severance Hospital, Yonsei University Health System_Endocrinology, Seoul · Seoul National University Bundang Hospital_Endocrinology, Seoungnam-si

    Registry updated 2026-09-30

  • NCT07321886

    A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

    Trial Treatment · Phase 3 · Eli Lilly and Company

    Gachon University Gil Medical Center, Namdong-gu · Konyang University Hospital, Seogu · Seoul National University Bundang Hospital, Seongnam · Seoul National University Hospital, Seoul · Pusan National University Yangsan Hospital, Yangsan

    Registry updated 2026-09-22

  • NCT07638241

    Agentic AI Personalized Dietary Management Study

    Trial Treatment · Seoul National University Hospital

    Seoul National University Hospital Healthcare System Gangnam Center, Seoul

    Registry updated 2026-09-15

  • NCT07668401

    AMAZE 13: A Research Study Investigating How Well the Medicine Zenagamtide Helps People in Asia With Excess Body Weight Lose Weight

    Trial Treatment · Phase 3 · Novo Nordisk A/S

    Kyungpook National University Hospital_Family Medicine, Daegu · Seoul National University Hospital_Family Medicine, Seoul · Severance Hospital, Yonsei University Health System_Family Medicine, Seoul · Konkuk University Medical Center_Endocrinology, Seoul · Seoul National University Bundang Hospital_Endocrinology, Seoungnam-si · Ajou University Hospital_Family Medicine, Suwon · Pusan National University Yangsan Hospital_Family Medicine, Yangsan

    Registry updated 2026-08-24

  • NCT07567001

    A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

    Trial Treatment · Phase 3 · Novo Nordisk A/S

    Hallym University Sacred Heart Hospital_Cardiology, Anyang-si · Keimyung University Dongsan Hospital_Cardiology, Daegu · Chungnam National University Hospital_Cardiology, Daejeon · Chonnam National University Hospital_Cardiology, Gwangju · Inha University Hospital_Cardiology, Incheon · Gachon University Gil Medical Center_Cardiology, Incheon · Seoul National University Bundang Hospital_Cardiology, Seongnam-si · Severance Hospital, Yonsei University Health System_Cardiology, Seoul · Korea University Guro Hospital_Cardiology, Seoul · Samsung Medical Center_Cardiology, Seoul · The Catholic University of Korea, Seoul ST. Mary's Hospital_Cardiology, Seoul · Asan Medical Center_Cardiology, Seoul · Hanyang university seoul hospital_Cardiology, Seoul · Gangnam Severance Hospital_Cardiology, Seoul · Korea University Anam Hospital_Cardiology, Seoul · Seoul National University Hospital_Cardiology, Seoul · Ajou University Hospital_Cardiology, Suwon · The Catholic University of Korea. Uijeongbu St. Mary's Hospital_Cardiology, Uijeongbu-si · Wonju Severance Christian Hospital_Cardiology, Wŏnju · Pusan National University Yangsan Hospital_Cardiology, Yangsan

    Registry updated 2026-08-18

  • NCT04284943

    Surgical TreAtment for Obesity Related Disease and Onco-Metabolic Surgery

    Trial Treatment · Korea University Anam Hospital

    Korea University Anam Hospital, Seoul

    Registry updated 2026-08-07

All Obesity trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Obesity trials in South Korea – Frontlight Research